NCT04833569 is a Phase 1 clinical trial of ICG-PDT in Peri-Implantitis, sponsored by King Saud University.

Who is sponsoring NCT04833569?

NCT04833569 is sponsored by King Saud University.

What drugs are being tested in NCT04833569?

Interventions in NCT04833569: ICG-PDT, peri-implant mechanical debridement.

What condition does NCT04833569 study?

NCT04833569 studies Peri-Implantitis.

Is NCT04833569 still recruiting?

NCT04833569 is currently completed. Last updated 6 April 2021.

Last reviewed 2021-04-06 · How we verify

NCT04833569

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ICG-PDT, Periimplantitis, Diabetes Mellitus

Completed Phase 1 Last updated 6 April 2021

What this trial tests

Phase 1 trial testing ICG-PDT in Peri-Implantitis in 50 participants. Completed in 10 March 2021.

Timeline

20 September 2020

Primary endpoint
15 February 2021

10 March 2021

Quick facts

Lead sponsor	King Saud University
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	20 September 2020
Primary completion	15 February 2021
Estimated completion	10 March 2021
Sites	1 location across Saudi Arabia

Drugs / interventions tested

ICG-PDT — full drug profile →
peri-implant mechanical debridement

Conditions studied

Peri-Implantitis — all drugs for Peri-Implantitis →

Sponsor

King Saud University

Who can join

45 and older, any sex, with Peri-Implantitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the effect of photodynamic therapy (indocyanine green mediated) on the clinical, biological and inflammatory aspects was assessed in diabetic patients having peri-implantitis

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical, bacterial, and inflammatory outcomes of indocyanine green-mediated photodynamic therapy for treating periimplantitis among diabetic patients: A randomized controlled clinical trial.
Labban N, Shibani NA, Al-Kattan R, Alfouzan AF, et al · · 2021 · cited 31× · PMID 34033934 · DOI 10.1016/j.pdpdt.2021.102350

Verify or expand the search:

Other recruiting trials for Peri-Implantitis

Currently open trials in the same condition.

NCT07012915 — Immunological-Clinical Evaluation of the Etiopathogenesis of Peri-Implantitis · NA · recruiting
NCT06679283 — Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF) · NA · recruiting
NCT06017817 — Antibacterial Photodynamic Therapy in the Management of Peri-implantitis · NA · recruiting
NCT06364982 — Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease. · recruiting
NCT06288919 — Erythritol vs Ultrasonic Scaler Prophylaxis Systems on Dental Implants With Crowns Made by Different Materials · NA · active not recruiting

Other King Saud University trials

Trials by the same sponsor.

NCT07500493 — Tele-Rehabilitation in Adults With Cystic Fibrosis · NA · not yet recruiting
NCT07324044 — Chrono-ALIGN: A Chronotype-Based Chrono-Nutrition Intervention in Post-Bariatric Patients · NA · not yet recruiting
NCT07288385 — Investigating the Feasibility of Combining Virtual Reality and Bilateral Transcranial Direct Stimulation to Improve Uppe · NA · recruiting
NCT07475195 — Oral Probiotics and Denture Care in Saudi Arabia: Evaluating Knowledge, Practices, and the Future of Innovative Hygiene · completed
NCT07159152 — Effects of Coffee Versus Hibiscus Tea Consumption During Prolonged Sitting on Blood Pressure and Heart Rate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04833569 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by King Saud University
Last refreshed: 6 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04833569.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing